-
Women in Texas face hurdles when it comes to getting long-acting reversible contraceptive (LARC) methods following cuts to the state family planning budget by the 2011 Texas State Legislature.
-
News from the KEEPS Study: HRT Does Not Decrease Progression of Atherosclerosis Over 4 Years of Treatment
-
In this prospective cohort study of 161 nulligravid women, there was no reliable threshold of uterine length or flexion angle measurements that were predictive of painful or difficult insertions. History of severe dysmenorrhea was the only predictor of insertion pain.
-
Barriers to guideline-adherent care for advanced ovarian cancer are impacted by geographic proximity to a high-volume hospital and travel distance. However, these geographic barriers disproportionately affect racial minorities and women of lower socioeconomic status.
-
Prolapse occurs along a spectrum from early and asymptomatic to advanced and symptomatic. The authors define anatomic cutoffs that are likely to result in symptomatic and clinically significant prolapse.
-
This is an eight-week, cluster-randomized, controlled trial at a single institution study (Stanford Hospital) comparing a traditional one-way paging system to the use of a HIPAA-compliant group messaging (HCGM) application for smartphones.
-
The authors present an updated review of the use of tissue plasminogen activator in patients with acute ischemic stroke.
-
In this retrospective study of extubation outcomes in five ICUs at a single medical center, patients extubated at night had no increase in adverse events and their mortality rates and lengths of ICU stay were lower. However, these results were likely affected by the high proportion of post-cardiac-surgery patients in the nighttime extubation group.
-
This observational cohort study found that reduced ICU bed availability is associated with increased rates of ICU readmission as well as ward cardiac arrest if medical ICU beds were on shortage.
-
This study completes the Imazio et al trilogy on the treatment of pericarditis and suggests that colchicine is the drug of first choice for acute pericarditis, first recurrences, and multiple recurrences.
